Tronox reported adjusted EBITDA of $101 million, up 36% year-over-year and 38% sequentially. It forecast $80 to $90 million of fourth-quarter adjusted EBITDA and agreed with JX Advanced Metals to jointly fund approximately $32 million of rare-earth studies.
TROX · Tronox Holdings plc
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Up next
Latest documents
Tronox Holdings plc reported third-quarter net sales of $827 million, up 18%. As of September 30, 2026, total available liquidity was $509 million and total debt was $3.2 billion.
Tronox Holdings plc declared a quarterly cash dividend of $0.05 per share, payable on January 15, 2027 to shareholders of record at the close of business on November 16, 2026.
Tronox Holdings plc appointed Yasser Al-Daajani to its Board effective October 27, 2026, following nomination by Cristal International Holdings B.V. He will receive a $100,000 annual cash retainer and an annual equity grant of restricted share units valued at $150,000.
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
AI Brief
Q3 FY26 earnings call · Nov 5, 2026TL;DR. Revenue rose 18%, adjusted EBITDA increased to $101 million, pricing gains held, cost savings are on track, and trade initiatives advanced. However, full-year free cash flow is now expected to use $25-$50 million as input-cost headwinds, weaker demand and expected Q4 volume declines pressure performance.
- + Revenue increased 18% year over year to $827 million, driven by higher sales volumes and average selling prices.
- + Adjusted EBITDA increased to $101 million from $73 million in the second quarter, while margin improved to 12.2%.
- + Pricing actions were successfully implemented across all markets, strengthening the commercial position.
- + Pricing gains held despite softer-than-anticipated demand and contributed to sequential improvement in adjusted EBITDA margins.
- + The cost improvement program is on track to deliver more than $175 million of run-rate savings by the end of 2026, exceeding its original target.
- + Trade actions, including reinstated Indian duties and the EU anti-absorption investigation, are progressing toward a more level competitive environment.
- − Full-year 2026 free cash flow is now expected to use $25-$50 million due to raw material headwinds and weaker sales volumes.
- − Q4 adjusted EBITDA is expected to be $80-$90 million, with approximately $15-$20 million of higher-than-expected input costs.
- − Q4 TiO2 volumes are expected to decline sequentially by a high-single to low double-digit percentage amid seasonality and lower demand.
- − Tronox reported a net loss attributable to Tronox of $55 million, or $0.34 per diluted share.
- − Higher production and freight costs and unfavorable exchange rates offset part of the pricing benefit.
- − Chinese chloride TiO2 exports increased 50% year over year, presenting a continuing competitive challenge.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA (non-U.S. GAAP) non-GAAP | $135M | Six Months Ended June 30, 2026 | — |
| Adjusted EBITDA Margin non-GAAP | 8.4% | Q2 2026 | — |
| Capital expenditures | $45M | Q2 2026 | — |
| Diluted adjusted net loss per share attributable to Tronox Holdings plc (non-U.S. GAAP) non-GAAP | -$0.51 | Three Months Ended June 30, 2026 filing | — |
| EBITDA (non-U.S. GAAP) non-GAAP | $87M | Six Months Ended June 30, 2026 | — |
| Free cash flow (non-U.S. GAAP) non-GAAP | -$75M | Six Months Ended June 30, 2026 | — |
| Net debt | $3.04B | June 30, 2026 | — |
| Net debt to trailing-twelve month Adjusted EBITDA (non-U.S. GAAP) non-GAAP | 11.4 | June 30, 2026 | — |
| Trailing-twelve month Adjusted EBITDA (non-U.S. GAAP) non-GAAP | $266M | June 30, 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
TROX
this stock
Tronox Holdings plc
|
$418.43M | -37.2% | -5.7% | — | 11.5% |
|
SHECF
Shin-Etsu Chemical Co., Ltd.
|
$65.47B | +12.7% | — | — | 0.1% |
|
DOW
Dow Inc.
|
$23.92B | +41.3% | -7.0% | — | 3.8% |
|
CE
Celanese Corp
|
$5.64B | +21.6% | -7.1% | 21.7 | 5.6% |
|
MEOH
Methanex Corp
|
$5.45B | +77.5% | — | — | 3.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- Filed
- Nov 5, 2026
- This year
- 19
Tronox Holdings plc reported third-quarter net sales of $827 million, up 18%. As of September 30, 2026, total available liquidity was $509 million and total debt was $3.2 billion.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| TROX | +4.4% | -24.5% | -65.8% | -27.2% | -37.2% |
| SPY | +2.6% | -1.2% | +0.5% | -0.2% | +10.6% |
| vs SPY | +1.8% | -23.3% | -66.3% | -27.0% | -47.8% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.